ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis,
Casey's General Stores, Inc. (NASDAQ: CASY) is projected to release financial results for its second quarter fiscal 2024, after the closing bell on Dec. 11, 2023.